Peter Karsten

814 total citations
8 papers, 643 citations indexed

About

Peter Karsten is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Peter Karsten has authored 8 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Neurology and 2 papers in Molecular Biology. Recurrent topics in Peter Karsten's work include Cytokine Signaling Pathways and Interactions (2 papers), Amyotrophic Lateral Sclerosis Research (2 papers) and Nuclear Receptors and Signaling (2 papers). Peter Karsten is often cited by papers focused on Cytokine Signaling Pathways and Interactions (2 papers), Amyotrophic Lateral Sclerosis Research (2 papers) and Nuclear Receptors and Signaling (2 papers). Peter Karsten collaborates with scholars based in Germany, United Kingdom and United States. Peter Karsten's co-authors include Aaron Voigt, Jörg B. Schulz, Martin P. Zeidler, Konstanze F. Winklhofer, Fabienne C. Fiesel, Till Marquardt, Stephanie Weber, Daniel Müller, Philipp J. Kahle and Ellen Gerhardt and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and Human Molecular Genetics.

In The Last Decade

Peter Karsten

8 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Karsten Germany 8 338 254 168 101 97 8 643
Kristin A. Politi United States 6 326 1.0× 188 0.7× 74 0.4× 43 0.4× 102 1.1× 6 557
Elie Needle United States 9 231 0.7× 406 1.6× 170 1.0× 36 0.4× 26 0.3× 9 741
J. Gavin Daigle United States 7 451 1.3× 291 1.1× 85 0.5× 28 0.3× 186 1.9× 9 670
Goran Periz United States 12 849 2.5× 461 1.8× 188 1.1× 33 0.3× 294 3.0× 21 1.2k
Claudia Abou‐Ajram Germany 11 511 1.5× 347 1.4× 75 0.4× 24 0.2× 191 2.0× 13 794
F J Doherty United Kingdom 15 453 1.3× 190 0.7× 74 0.4× 102 1.0× 40 0.4× 24 831
Emily Foran United States 9 255 0.8× 199 0.8× 145 0.9× 24 0.2× 129 1.3× 9 573
Roger Moser Switzerland 7 598 1.8× 177 0.7× 224 1.3× 198 2.0× 22 0.2× 7 971
Sergey S. Novoselov United Kingdom 14 751 2.2× 305 1.2× 296 1.8× 31 0.3× 106 1.1× 20 1.0k
Allison Citro United States 5 720 2.1× 480 1.9× 142 0.8× 31 0.3× 233 2.4× 6 1.0k

Countries citing papers authored by Peter Karsten

Since Specialization
Citations

This map shows the geographic impact of Peter Karsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Karsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Karsten more than expected).

Fields of papers citing papers by Peter Karsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Karsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Karsten. The network helps show where Peter Karsten may publish in the future.

Co-authorship network of co-authors of Peter Karsten

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Karsten. A scholar is included among the top collaborators of Peter Karsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Karsten. Peter Karsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Butzlaff, Malte, Peter Karsten, Josephine Ng, et al.. (2015). Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity. Human Molecular Genetics. 24(13). 3623–3637. 57 indexed citations
2.
Zhang, Li, Peter Karsten, Nicole Exner, et al.. (2013). TRAP1 rescues PINK1 loss-of-function phenotypes. Human Molecular Genetics. 22(14). 2829–2841. 81 indexed citations
3.
Karsten, Peter, et al.. (2013). Drosophila as a screening tool to study human neurodegenerative diseases. Journal of Neurochemistry. 127(4). 453–460. 73 indexed citations
4.
Voigt, Aaron, A. Kathrin Lutz, Ellen Gerhardt, et al.. (2012). The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity. PLoS Genetics. 8(2). e1002488–e1002488. 109 indexed citations
5.
Butzlaff, Malte, Peter Karsten, Mikael Simons, et al.. (2012). Large-Scale Screen for Modifiers of Ataxin-3-Derived Polyglutamine-Induced Toxicity in Drosophila. PLoS ONE. 7(11). e47452–e47452. 33 indexed citations
6.
Voigt, Aaron, Fabienne C. Fiesel, Daniel Müller, et al.. (2010). TDP-43-Mediated Neuron Loss In Vivo Requires RNA-Binding Activity. PLoS ONE. 5(8). e12247–e12247. 164 indexed citations
7.
Karsten, Peter, et al.. (2005). Mutational analysis reveals separable DNA binding and trans-activation of Drosophila STAT92E. Cellular Signalling. 18(6). 819–829. 28 indexed citations
8.
Karsten, Peter, et al.. (2002). Cloning and expression of Drosophila SOCS36E and its potential regulation by the JAK/STAT pathway. Mechanisms of Development. 117(1-2). 343–346. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026